NOTICE: Through the COVID-19 declared Emergency, the Board is closed to visitors but is continuing all operations remotely. To contact the Board, go to the “Contact Us” section at the bottom of this page.

CORONAVIRUS OMNIBUS LEGISLATION (HB197)
• General Guidance for Initial Licensing Authorized by the Coronavirus Omnibus Legislation (HB197)
• Extension of Licenses Due to Expire – COVID-19 Declared Emergency
• FAQs for Initial Licensing Authorization
• Extension of Approvals: Education Programs, Training Programs, OBN Approvers of CE

EXPEDITED LICENSING
• Ohio law authorizes nursing practice in emergencies without an Ohio nursing license and the Board is expediting the issuance of temporary permits and all license types.
• Click here for the full Board statement regarding the mobility of nurses

NURSING EDUCATION PROGRAMS AND TRAINING PROGRAMS
• Click here for numerous Guidance and Communication documents and see “COVID-19 Communications to Program Administrators” on that page.
• Extension of Approvals: Education Programs, Training Programs, OBN Approvers of CE
• NCLEX Examinations: Update
• See https://home.pearsonvue.com/for reopening of limited numbers of NCLEX testing centers
• Practice-Academic Partnerships During COVID-19 Emergency Policy Brief by U.S. Nursing Leaders
• Board Statement on Practice-Academic Partnership Policy Brief
• Scholarship Opportunities for Nurse Practitioner Students Specializing in Psychiatric Mental Health. Click here: https://bhw.hrsa.gov/loans-scholarships/nurse-corps/scholarship

APRNs AND PRESCRIBING (Also see “Practice” section below)
• APRNs, monitor https://www.pharmacy.ohio.gov/ and https://www.med.ohio.gov/ for updates affecting your practice
• DEA Guidance on Oral CII Prescriptions (NEW)
• Guidance for APRNs Who Provide Patient Care as an RN-COVID-19
• See the DEA COVID-19 Information Page on the Diversion Control Divisions web for guidance; direct questions concerning COVID-19 to the Policy email box at Natural.Disaster@usdoj.gov
• Chloroquine phosphate and hydroxychloroquine sulfate products for COVID treatment
• Pharmacy Board Statement on CNPs, CNSs, CNMs, PAs in the Management of Pharmacist Consult Agreements
• National APRN Certification Organizations – Extension Policies COVID-19 Update

PRACTICE
• RN and LPN practice in the COVID-19 Health Care Environment
• PPE Information-click here for numerous documents and see “COVID-19 Information for PPE”
• Practice-Academic Partnerships During COVID-19 Emergency Policy Brief by U.S. Nursing Leaders
• Board Statement on Practice-Academic Partnership Policy Brief
• Chloroquine phosphate and hydroxychloroquine sulfate products for COVID treatment
• Pharmacy Board Statement on Authorization for Nurses to Stock Automated Drug Storage Systems